Merck Prestige® 2

PRESTIGE flu-containing equine vaccines provide the most updated flu strains available. Formulated to minimize reactions and maximize protection Advanced filtration process through the Antigen Purification System (APS™) Exceptional safety profile with the exclusive Havlogen® Adjuvant A combination of inactivated, concentrated, adjuvanted, tissue culture origin equine herpesvirus types 1 and 4 (EHV-1 and EHV-4) and equine influenza virus type H3N8 strains EIV A/eq/Florida/RW/13, EIV A/Equine 2/Kentucky/02 American, EIV A/eq/Richmond/1/07. Indications This product has been shown to be effective for the vaccination of healthy horses 6 months of age or older against equine influenza (EIV), equine herpesvirus type 1 (EHV-1) and equine herpesvirus type 4 (EHV-4). Duration of immunity has been shown at 6 months for EIV. Duration of immunity for EHV-1 and EHV-4 has not been established. For more information regarding safety and efficacy data, go to productdata